diane 2 mg/0,035 mg obložene tablete
bayer d.o.o. - etinilestradiol; ciproteronacetat - obložena tableta - etinilestradiol 0,035 mg / 1 tableta ciproteronacetat2 mg / 1 tableta; ciproteronacetat 2 mg / 1 tableta - ciproteron in estrogen
bellune 2 mg/0,035 mg obložene tablete
pliva ljubljana d.o.o., ljubljana - etinilestradiol; ciproteronacetat - obložena tableta - etinilestradiol 0,035 mg / 1 tableta ciproteronacetat2 mg / 1 tableta; ciproteronacetat 2 mg / 1 tableta - ciproteron in estrogen
bellune 2 mg/0,035 mg obložene tablete
pliva ljubljana d.o.o., ljubljana - etinilestradiol; ciproteronacetat - obložena tableta - etinilestradiol 0,035 mg / 1 tableta ciproteronacetat2 mg / 1 tableta; ciproteronacetat 2 mg / 1 tableta - ciproteron in estrogen
climen obložene tablete
bayer pharma ag - estradiolvalerat; ciproteronacetat - obložena tableta - estradiolvalerat 2 mg / 1 tableta ciproteronacetat1 mg / 1 tableta; ciproteronacetat 1 mg / 1 tableta - ciproteron in estrogen
pegasys
pharmaand gmbh - peginterferon alfa-2a - hepatitis c, chronic; hepatitis b, chronic - immunostimulants, - chronic hepatitis b adult patients pegasys is indicated for the treatment of hepatitis b envelope antigen (hbeag)-positive or hbeag-negative chronic hepatitis b (chb) in adult patients with compensated liver disease and evidence of viral replication, increased alanine aminotransferase (alt) and histologically verified liver inflammation and/or fibrosis (see sections 4. 4 in 5. paediatric patients 3 years of age and older pegasys is indicated for the treatment of hbeag-positive chb in non-cirrhotic children and adolescents 3 years of age and older with evidence of viral replication and persistently elevated serum alt levels. glede na odločitev, da začne zdravljenje v pediatrični bolniki glej točki 4. 2, 4. 4 in 5. chronic hepatitis c adult patients pegasys is indicated in combination with other medicinal products, for the treatment of chronic hepatitis c (chc) in patients with compensated liver disease (see sections 4. 2, 4. 4 in 5. za virus hepatitisa c (hcv) genotip določene dejavnosti, glej točki 4. 2 in 5. paediatric patients 5 years of age and older pegasys in combination with ribavirin is indicated for the treatment of chc in treatment-naïve children and adolescents 5 years of age and older who are positive for serum hcv-rna. ko se odločate za začetek zdravljenja v otroštvu, je pomembno, da preuči zaviranja rasti povzročijo kombinacija terapije. reverzibilnost zaviranja rasti je negotova. odločitev za zdravljenje mora biti vložena na podlagi primera (glej poglavje 4.
rivastigmine 3m health care ltd
3m health care limited - rivastigmin - alzheimerjeva bolezen - psychoanaleptics, , anticholinesterases - simptomatsko zdravljenje blage do zmerno hude alzheimerjeve demence.
neophyr 450 ppm mol/mol medicinski plin, stisnjeni
sol s.p.a. - dušikov(ii) oksid - medicinski plin, stisnjeni - dušikov(ii) oksid 450 ppm / 1 jeklenka - dušikov(ii) oksid
neophyr 1000 ppm mol/mol medicinski plin, stisnjeni
sol s.p.a. - dušikov(ii) oksid - medicinski plin, stisnjeni - dušikov(ii) oksid 1000 ppm / 1 jeklenka - dušikov(ii) oksid
neophyr 225 ppm mol/mol medicinski plin, stisnjeni
sol s.p.a. - dušikov(ii) oksid - medicinski plin, stisnjeni - dušikov(ii) oksid 225 ppm / 1 jeklenka - dušikov(ii) oksid
neophyr 1000 ppm mol/mol medicinski plin, stisnjeni
sol s.p.a. - dušikov(ii) oksid - medicinski plin, stisnjeni - dušikov(ii) oksid 1000 ppm / 1 jeklenka - dušikov(ii) oksid